[1] ZHAO H W, WANG Y, LI Y Q, et al. Research advances in current drugs targeting hyperlipidemia(Review)[J]. Mol Med Rep, 2025, 32(4): 1-17. doi:  10.3892/mmr.2025.13623
[2] GILES L A. Hyperlipidemia prevention and management utilizing lifestyle changes[J]. J Midwifery Womens Health, 2024, 69(3): 361-369. doi:  10.1111/jmwh.13637
[3] CHENG D Y, ZHANG M, ZHENG Y Z, et al. α-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1α/Nrf2 pathway[J]. Redox Biol, 2024, 74: 103230. doi:  10.1016/j.redox.2024.103230
[4] LI L, GUO Z, ZHAO Y, et al. The impact of oxidative stress on abnormal lipid metabolism-mediated disease development. Arch Biochem Biophys, 2025, 766: 110348.
[5] Murphy JM, Jeong K, Tran DTK, et al. Nuclear FAK in endothelium: An intrinsic inhibitor of NF-κB activation in atherosclerosis. Atherosclerosis, 2023, 379: 117189.
[6] SINGH I P, AHMAD F, GORE D D, et al. Therapeutic potential of seabuckthorn: a patent review(2000-2018)[J]. Expert Opin Ther Pat, 2019, 29(9): 733-744. doi:  10.1080/13543776.2019.1648434
[7] 薛延团, 张晓凤, 张育浩, 等. 沙棘甾醇降血脂作用评价[J]. 中国食品添加剂, 2019, 30(7): 129-137. doi:  10.3969/j.issn.1006-2513.2019.07.013
[8] LV W J, HUANG J Y, LIN J, et al. Phytosterols alleviate hyperlipidemia by regulating gut microbiota and cholesterol metabolism in mice[J]. Oxid Med Cell Longev, 2023, 2023: 6409385.
[9] IYANDA A, ADELEKE R, BOAKYE K, et al. Hyperlipidemia risk factors among middle-aged population in the United States[J]. J Prev Interv Community, 2025, 53(3): 489-512. doi:  10.1080/10852352.2025.2480455
[10] NEI Y, ZHANG M, HUANG Y. W. Research Progress on Natural Compounds Inhibiting HMG-CoA Reductase for Improving Cardiovascular and Cerebrovascular Diseases[J]. J. Food Saf. Qual, 2021, 12: 7333-7341.
[11] CESARONE M R, HU S, BELCARO G, et al. Borderline hyperlipidemia: preventive supplementation with berberine phospholipids to prevent early atherosclerosis evolution[J]. Minerva Med, 2025, 116(4): 285-291. doi:  10.23736/s0026-4806.25.09637-5
[12] JAŚNIEWSKA A, DIOWKSZ A. Wide spectrum of active compounds in sea buckthorn(Hippophae rhamnoides)for disease prevention and food production[J]. Antioxidants, 2021, 10(8): 1279. doi:  10.3390/antiox10081279
[13] CRISTE A, URCAN A C, BUNEA A, et al. Phytochemical composition and biological activity of berries and leaves from four Romanian Sea buckthorn(Hippophae rhamnoides L. )varieties[J]. Molecules, 2020, 25(5): 1170. doi:  10.3390/molecules25051170
[14] LI J, GUO J H, YUEN M, et al. The comparative effects of ω-7 fatty acid-rich sea buckthorn oil and ω-3 fatty acid-rich DHA algal oil on improving high-fat diet-induced hyperlipidemia[J]. Food Funct, 2025, 16(4): 1241-1253. doi:  10.1039/D4FO04961F
[15] KOPČEKOVÁ J, MRÁZOVÁ J, FATRCOVÁ-ŠRAMKOVÁ K, et al. Benefits of sea buckthorn juice consumption in women of productive age with hypercholesterolemia[J]. Rocz Panstw Zakl Hig, 2023, 74(2): 187-193. doi:  10.32394/rpzh.2023.0258
[16] ZHOU F F, ZHANG J, ZHAO A, et al. Effects of sea buckthorn puree on risk factors of cardiovascular disease in hypercholesterolemia population: a double-blind, randomized, placebo-controlled trial[J]. Anim Biotechnol, 2022, 33(5): 955-963. doi:  10.1080/10495398.2020.1853139
[17] SHAIMAA S ABDULLAH*, AHMED R ABU RAGHIF. Effect of Apremilast in Experimentally Induced Hyperlipidemic Mice[J]. J Carcinog, 2023, 22(1): 20-27.
[18] NAIR A, JACOB S. A simple practice guide for dose conversion between animals and human[J]. J Basic Clin Pharma, 2016, 7(2): 27. doi:  10.4103/0976-0105.177703
[19] Kirkley A. Identifying hubs in directed networks. Phys Rev E. 2024 Mar;109(3-1): 034310.
[20] ZHI D D, HE X Y, YANG L F, et al. Royal jelly acid alleviates diet-induced hyperlipidemia through regulation of oxidative stress and tryptophan metabolism[J]. Eur J Pharmacol, 2025, 998: 177500. doi:  10.1016/j.ejphar.2025.177500
[21] 施春桥, 林娅宁, 俞佳, 等. 基于CiteSpace知识图谱的沙棘研究热点与趋势可视化分析[J]. 中药与临床, 2025, 16(6): 51-57.
[22] 王庆芬, 陈根光, 黄丽珊, 等. 基于网络药理学探讨黄芩治疗痤疮活性成分及作用机制[J]. 解放军药学学报, 2024, 37(1): 19-24. doi:  10.3969/j.issn.1008-9926.2024.01.006
[23] KATSAROS I, SOTIROPOULOU M, VAILAS M, et al. Quercetin’s potential in MASLD: investigating the role of autophagy and key molecular pathways in liver steatosis and inflammation[J]. Nutrients, 2024, 16(22): 3789. doi:  10.3390/nu16223789
[24] CHIANG M C, TSAI T Y, WANG C J. The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms[J]. Int J Mol Sci, 2023, 24(7): 6328. doi:  10.3390/ijms24076328
[25] JIANG L, YI R, CHEN H, et al. Quercetin alleviates metabolic-associated fatty liver disease by tuning hepatic lipid metabolism, oxidative stress and inflammation[J]. Anim Biotechnol, 2025, 36: 2442351. doi:  10.1080/10495398.2024.2442351
[26] MAJDALAWIEH A, RO H S. Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages[J]. Mediators Inflamm, 2010, 2010: 823821.
[27] GUNGOR H, EKICI M, ATES M B. Lipid-lowering, anti-inflammatory, and hepatoprotective effects of isorhamnetin on acetaminophen-induced hepatotoxicity in mice[J]. Drug Chem Toxicol, 2023, 46(3): 566-574. doi:  10.1080/01480545.2022.2069256
[28] NAKSURIYA O, DAOWTAK K, TIMA S, et al. Hydrolyzed flavonoids from Cyrtosperma johnstonii with superior antioxidant, antiproliferative, and anti-inflammatory potential for cancer prevention[J]. Molecules, 2022, 27(10): 3226. doi:  10.3390/molecules27103226
[29] GAUR V, BERA S. Microbial canthaxanthin: an orange-red keto carotenoidwith potential pharmaceutical applications[J]. BioTechnologia, 2023, 104(3): 315-328. doi:  10.5114/bta.2023.130733
[30] LI S, WANG Y, ZHAO C, et al. Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis[J]. Iran J Basic Med Sci, 2019, 22(11): 1275-1282.
[31] LO C H, ZENG J L. TNF as a mediator of metabolic inflammation and body-brain interaction in obesity-driven neuroinflammation and neurodegeneration[J]. Ageing Res Rev, 2025, 112: 102891. doi:  10.1016/j.arr.2025.102891
[32] LOPEZ-CASTEJON G, BROUGH D. Understanding the mechanism of IL-1β secretion[J]. Cytokine Growth Factor Rev, 2011, 22(4): 189-195. doi:  10.1016/j.cytogfr.2011.10.001
[33] HARDAWAY A L, PODGORSKI I. Il-1β, rage and Fabp4: targeting the dynamic trio in metabolic inflammation and related pathologies[J]. Future Med Chem, 2013, 5(10): 1089-1108. doi:  10.4155/fmc.13.90
[34] YANG C N, FU J X, ZHENG F S, et al. Aconitine promotes ROS-activated P38/MAPK/Nrf2 pathway to inhibit autophagy and promote myocardial injury[J]. J Cardiothorac Surg, 2024, 19(1): 665. doi:  10.1186/s13019-024-03149-0
[35] KINNUNEN P C, LUKER G D, LUKER K E, et al. Computational modeling implicates protein scaffolding in p38 regulation of Akt[J]. J Theor Biol, 2022, 555: 111294. doi:  10.1016/j.jtbi.2022.111294
[36] AJOOLABADY A, PRATICO D, LIN L, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms[J]. Cell Death Dis, 2024, 15(11): 817. doi:  10.1038/s41419-024-07166-8
[37] WAZIR M, OLANREWAJU O A, YAHYA M, et al. Lipid disorders and cardiovascular risk: a comprehensive analysis of current perspectives[J]. Cureus, 2023, 15(12): e51395. doi:  10.7759/cureus.51395
[38] LIBBY P, SOEHNLEIN O. Inflammation in atherosclerosis: Lessons and therapeutic implications[J]. Immunity, 2025, 58(10): 2383-2401. doi:  10.1016/j.immuni.2025.09.012
[39] PRASAD K, KHAN A S, BHANUMATHY K K. Does AGE–RAGE stress play a role in the development of coronary artery disease in obesity?[J]. Int J Angiol, 2022, 31(1): 1-9. doi:  10.1055/s-0042-1742587
[40] CHEN D, WANG L D, JIANG T, et al. Flow shear force destabilizes carotid plaques by affecting CHOP and GRP78 proteins[J]. J Stroke Cerebrovasc Dis, 2024, 33(9): 107851. doi:  10.1016/j.jstrokecerebrovasdis.2024.107851